Trial Details
COMPLETEDBasic Information
| Clinical ID | c4536 |
|---|---|
| Identifier | NCT00356408 |
| Trial Title | Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab pegol |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2007-01 |
|---|---|
| Primary Completion Date | 2010-02 |
| Completion Date | 2010-02 |